Moses Adeyanju

560 total citations
8 papers, 471 citations indexed

About

Moses Adeyanju is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Moses Adeyanju has authored 8 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Moses Adeyanju's work include Cancer-related Molecular Pathways (3 papers), Cell death mechanisms and regulation (2 papers) and Breast Cancer Treatment Studies (2 papers). Moses Adeyanju is often cited by papers focused on Cancer-related Molecular Pathways (3 papers), Cell death mechanisms and regulation (2 papers) and Breast Cancer Treatment Studies (2 papers). Moses Adeyanju collaborates with scholars based in United States and China. Moses Adeyanju's co-authors include Fitsum Hagos, Wendy Recant, OI Olopade, Rosemarie Mick, Ahmad R. Safa, Curtis B. Thompson, Olufunmilayo I. Olopade, Ziwen Liu, Jun Ma and Deliang Cao and has published in prestigious journals such as International Journal of Cancer, American Journal of Clinical Pathology and Diagnostic Cytopathology.

In The Last Decade

Moses Adeyanju

8 papers receiving 461 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Moses Adeyanju United States	8	294	143	111	89	68	8	471
Gloria Bullock United States	11	377 1.3×	281 2.0×	97 0.9×	58 0.7×	28 0.4×	15	571
Akiko Sakashita Japan	11	481 1.6×	108 0.8×	30 0.3×	39 0.4×	69 1.0×	30	658
Thomas A. Lampkin United States	9	410 1.4×	259 1.8×	258 2.3×	84 0.9×	39 0.6×	11	631
Carol Swiderski United States	10	421 1.4×	291 2.0×	28 0.3×	121 1.4×	48 0.7×	13	650
Maria R. Abbattista New Zealand	9	235 0.8×	63 0.4×	77 0.7×	198 2.2×	14 0.2×	28	415
N Miyao Japan	9	349 1.2×	147 1.0×	63 0.6×	146 1.6×	194 2.9×	17	608
Yasunobu Kuraishi Japan	9	240 0.8×	138 1.0×	60 0.5×	67 0.8×	18 0.3×	16	429
J Yeargin United States	9	312 1.1×	284 2.0×	23 0.2×	74 0.8×	20 0.3×	10	509
Candice L. Horn United States	6	457 1.6×	251 1.8×	81 0.7×	64 0.7×	45 0.7×	10	552
Maribelis Ruiz United States	10	469 1.6×	240 1.7×	48 0.4×	150 1.7×	30 0.4×	11	685

Countries citing papers authored by Moses Adeyanju

Since Specialization

Citations

This map shows the geographic impact of Moses Adeyanju's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moses Adeyanju with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moses Adeyanju more than expected).

Fields of papers citing papers by Moses Adeyanju

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moses Adeyanju. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moses Adeyanju. The network helps show where Moses Adeyanju may publish in the future.

Co-authorship network of co-authors of Moses Adeyanju

This figure shows the co-authorship network connecting the top 25 collaborators of Moses Adeyanju. A scholar is included among the top collaborators of Moses Adeyanju based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moses Adeyanju. Moses Adeyanju is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Yan, Ruilan, Xuyu Zu, Jun Ma, et al.. (2007). Aldo–keto reductase family 1 B10 gene silencing results in growth inhibition of colorectal cancer cells: Implication for cancer intervention. International Journal of Cancer. 121(10). 2301–2306. 120 indexed citations

2.

Grushko, Tatyana A., M. Anne Blackwood, L. Philip Schumm, et al.. (2002). Molecular-cytogenetic analysis of HER-2/neu gene in BRCA1-associated breast cancers.. PubMed. 62(5). 1481–8. 69 indexed citations

3.

Adeyanju, Moses, Wendy Recant, Theodore Karrison, et al.. (2000). Human breast cancer susceptibility to paclitaxel therapy is independent of Bcl-2 expression.. PubMed. 6(10). 4043–8. 15 indexed citations

4.

Olopade, OI, Moses Adeyanju, Ahmad R. Safa, et al.. (1997). Overexpression of BCL-x protein in primary breast cancer is associated with high tumor grade and nodal metastases.. PubMed. 3(4). 230–7. 172 indexed citations

5.

Weisenberg, Elliot, et al.. (1995). Hodgkin’s Disease Associated With Chronic Lymphocytic Leukemia:Eight Additional Cases, Including Two of the Nodular Lymphocyte Predominant Type. American Journal of Clinical Pathology. 103(4). 479–484. 24 indexed citations

6.

Bohlander, Stefan K., et al.. (1995). Detection of CDKN2 deletions in tumor cell lines and primary glioma by interphase fluorescence in situ hybridization.. PubMed. 55(5). 984–8. 54 indexed citations

7.

Adeyanju, Moses, Gerald D. Dodd, Juan R. Madariaga, & Andrew Dekker. (1994). Ultrasonically guided fine‐needle aspiration biopsy of portal vein thrombosis: A cytomorphological study of 14 patients. Diagnostic Cytopathology. 11(3). 281–285. 7 indexed citations

8.

Adeyanju, Moses, et al.. (1994). Primary squamous cell carcinoma of the breast presenting as a nipple discharge.. PubMed. 38(1). 112–3. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact